BioCryst Pharmaceuticals
BCRX
#4937
Rank
ยฃ1.44 B
Marketcap
ยฃ5.62
Share price
-0.40%
Change (1 day)
5.27%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2026 (TTM): -ยฃ1.03

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ1.02. In 2025 the company made an earnings per share (EPS) of ยฃ0.95 an increase over its 2024 EPS that were of -ยฃ0.33.

EPS history for BioCryst Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.03-209.19%
2025ยฃ0.95-390.7%
2024-ยฃ0.33-63.56%
2023-ยฃ0.89-11.28%
2022-ยฃ1.0129.13%
2021-ยฃ0.78-4.63%
2020-ยฃ0.8210.2%
2019-ยฃ0.740%
2018-ยฃ0.7425.64%
2017-ยฃ0.594%
2016-ยฃ0.5727.12%
2015-ยฃ0.45-13.24%
2014-ยฃ0.5223.64%
2013-ยฃ0.42-30.38%
2012-ยฃ0.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-ยฃ2.35 129.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.18-313.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-ยฃ1.99 94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-ยฃ0.15-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-ยฃ1.15 12.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.30 222.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-ยฃ0.33-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ2.41 135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ3.82 273.33%๐Ÿ‡บ๐Ÿ‡ธ USA